Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  infection
Trial Type:  Supportive care
Trial Status:  Active
Sponsor of Trial:  NCI
Results 1-9 of 9 for your search:
Start Over
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Phase: Phase III
Type: Supportive care
Status: Active
Age: 6 months to 21 years
Sponsor: NCI, Other
Protocol IDs: ACCL0934, NCI-2011-02636, CDR0000695661, COG-ACCL0934, U10CA095861, NCT01371656
Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 3 months to 30 years
Sponsor: NCI, Other
Protocol IDs: ACCL0933, NCI-2011-02640, CDR0000695748, COG-ACCL0933, U10CA095861, NCT01307579
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
Phase: Phase III
Type: Supportive care
Status: Active
Age: 3 months to 20 years
Sponsor: NCI, Other
Protocol IDs: ACCL1131, NCI-2012-00102, CDR0000721415, COG-ACCL1131, U10CA095861, NCT01503515
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Phase: Phase III
Type: Supportive care
Status: Active
Age: 2 months to 21 years
Sponsor: NCI, Other
Protocol IDs: ACCL1034, NCI-2013-00595, COG-ACCL1034, UG1CA189955, U10CA095861, NCT01817075
SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 365 days to 18 years
Sponsor: NCI, Other
Protocol IDs: 11-001, NCT01574274
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Phase: Phase II
Type: Supportive care
Status: Approved-not yet active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: 13494, NCI-2015-00283, R01CA181045, NCT02396134
Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 9L-11-8, NCI-2013-00447, NCT01801046
Ovarian Cancer and Immune Response to Flu Vaccine
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 805443, UPCC 5806 (N01-A1-50024), NCT00478387
Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 99212, NCI-2012-00624, NCT01656044
Start Over